EUVIMEDEUVIMED entdecken
Crossref

Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis

Dai Ishikawa iD, Xiaochen Zhang, Kei Nomura, Tomoyoshi Shibuya iD, Mariko Hojo, Makoto Yamashita, Satoshi Koizumi, Fuhito Yamazaki, Susumu Iwamoto, Masato Saito, Keisuke Kunigo, Ryosuke Nakano und 3 weitere

Inflammatory Bowel Diseases · 04.11.2024 · 30 (11) · 2136-2145

DOI: 10.1093/ibd/izae080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 11.05.2024. Verfasst von Dai Ishikawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Colitis, Ulcerative, Feces, Interleukin-10. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The proportion of certain Bacteroidota species decreased in patients with ulcerative colitis, and the recovery of Bacteroidota is associated with the efficacy of fecal microbiota transplantation therapy. We hypothesized that certain Bacteroidota may advance ulcerative colitis treatment. Accordingly, we aimed to evaluate the anti-inflammatory effects of Bacteroidota strains isolated from donors.

Methods

Donors with proven efficacy of fecal microbiota transplantation for ulcerative colitis were selected, and Bacteroidota strains were isolated from their stools. The immune function of Bacteroidota isolates was evaluated through in vitro and in vivo studies.

Results

Twenty-four Bacteroidota strains were isolated and identified. Using an in vitro interleukin (IL)-10 induction assay, we identified 4 Bacteroidota strains with remarkable IL-10-induction activity. Of these, an Alistipes putredinis strain exhibited anti-inflammatory effects in a mouse model of colitis induced by sodium dextran sulfate and oxazolone. However, 16S rRNA gene-based sequencing analysis of A. putredinis cultures in the in vivo study revealed unexpected Veillonella strain contamination. A second in vitro study confirmed that the coculture exhibited an even more potent IL-10-inducing activity. Furthermore, the production of A. putredinis–induced IL-10 was likely mediated via toll-like receptor 2 signaling.

Conclusions

This study demonstrated that A. putredinis, a representative Bacteroidota species, exhibits anti-inflammatory effects in vivo and in vitro; however, the effects of other Bacteroidota species remain unexplored. Our fecal microbiota transplantation-based reverse translation approach using promising bacterial species may represent a breakthrough in microbiome drug development for controlling dysbiosis during ulcerative colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationColitis, UlcerativeFecesInterleukin-10AnimalsMiceHumansDisease Models, AnimalMaleBacteroidetesFemaleGastrointestinal MicrobiomeMice, Inbred C57BLRNA, Ribosomal, 16SDextran SulfateAnti-Inflammatory Agents

Stichwörter der Autor:innen

Bacteroidota strainsfecal microbiota transplantationulcerative colitis

Substanzen

Interleukin-10RNA, Ribosomal, 16SDextran SulfateAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.
  • Department of Regenerative Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
  • Research & Innovation Center, Kyowa Hakko Bio Co., Ltd, Ibaraki, Japan.
  • Research Core Function Laboratories, Research Unit, Research Division, Kyowa Kirin Co., Ltd, Tokyo, Japan.
  • Medical Pharmacology Department, Development Division, Kyowa Kirin Co., Ltd, Tokyo, Japan.
  • Research Strategy & Planning Department, Research Division, Kyowa Kirin Co., Ltd, Tokyo, Japan.

ORCID-Profile: Dai Ishikawa, Tomoyoshi Shibuya

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Ishikawa, D., Zhang, X., Nomura, K., Shibuya, T., Hojo, M., Yamashita, M., Koizumi, S., Yamazaki, F., Iwamoto, S., Saito, M., Kunigo, K., Nakano, R., Honma, N., Urakawa, I., & Nagahara, A. (2024). Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases, 30(11), 2136-2145. https://doi.org/10.1093/ibd/izae080

Vancouver

Ishikawa D, Zhang X, Nomura K, Shibuya T, Hojo M, Yamashita M, et al. Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases. 2024;30(11):2136-2145. doi:10.1093/ibd/izae080

BibTeX
@article{Ishikawa2024,
  author = {Ishikawa, Dai and Zhang, Xiaochen and Nomura, Kei and Shibuya, Tomoyoshi and Hojo, Mariko and Yamashita, Makoto and Koizumi, Satoshi and Yamazaki, Fuhito and Iwamoto, Susumu and Saito, Masato and Kunigo, Keisuke and Nakano, Ryosuke and Honma, Nakayuki and Urakawa, Itaru and Nagahara, Akihito},
  title = {Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {11},
  pages = {2136--2145},
  doi = {10.1093/ibd/izae080}
}
Kostenlos starten →